StockData
Obsidian Therapeutics, Inc. logo

Obsidian Therapeutics, Inc. (OBX) stock

OBXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026
$12.00−0.15 (-1.23%)

Close on Nov 20, 2026Market cap $741.28MP/E –Yield –

Obsidian Therapeutics cash

Cash and short-term investments held at the end of each period.

Obsidian Therapeutics's cash was $324.40M at Sep 30, 2026. For fiscal 2025 it was $80.50M, up 58.6% from the year before.

Annual cash

PeriodPeriod endValueChange
FY2025Dec 31, 2025$80.50M+58.6%
FY2024Dec 31, 2024$50.77M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$324.40M+768.2%
Q2 FY2026Jun 30, 2026$0-100.0%
Q1 FY2026Apr 10, 2026$0–
Q4 FY2025Dec 31, 2025$80.50M–
Q3 FY2025Sep 30, 2025$37.36M–
Q4 FY2024Dec 31, 2024$50.77M–

More Obsidian Therapeutics figures

See a number that looks wrong?